The Effect of Vitamin D Supplementation on the Increase in CD4 count of HIV/AIDS Patients Receiving Antiretroviral Therapy
DOI:
https://doi.org/10.32539/bsm.v5i1.186Keywords:
Vitamin D, Calcitriol, CD4 Count, HIV, Antiretroviral DrugsAbstract
Introduction. Vitamin D plays a role in health overall, but hypovitaminosis D still
occurs throughout the world. HIV/AIDS patients are prone to suffer from
hypovitaminosis D because of the infection itself and the side effects of antiretroviral
therapy. Various effort have been tried to improve the immune status of HIV/AIDS
patients, one of them is by adding vitamin D. Vitamin D acts as an antiinflammatory
so that it can prevent apoptosis of CD4 T cells and increase CD4 cell count.
Methods. This is a randomized control trial add on a study that aims to determine
the effect of vitamin D to increase in CD4 counts of HIV / AIDS patients who have
received antiretroviral drugs. Subjects were HIV / AIDS patients who had received
antiretroviral drugs. A total of 20 subjects were divided randomly into two groups;
one group received vitamin D (calcitriol 0.5 mcg per day) for eight weeks, and the
other group that received a placebo. Each group was measured of CD4 cell count
before and after treatment. Results. There was a significant increase in the CD4 cell
count of the vitamin D group (p = 0.046), but not in the CD4 cell count of both
groups (p = 0.985). The comparison of mean CD4 cell counts between groups before
treatment was not significantly different (p = 0.057), but after treatment, it became
significantly different (p = 0.040). Conclusion. Vitamin D has been successful in
increasing CD4 cell count in the vitamin D group, and it is recommended to give
HIV / AIDS patients to increase CD4 cell count.
Authors
- Mega Permata1*
- Harun Hudari1
- Mediarty1
- Taufik Indrajaya1
- 1Department of Internal Medicine, Faculty of Medicine, Universitas Sriwijaya, Palembang, Indonesia
Corresponding author Mega Permata — megaramdja73@gmail.com
Article history
- Submitted
- Accepted
- Published
Downloads
Published
Issue
Section
License
As our aim is to disseminate original research article, hence the publishing right is a necessary one. The publishing right is needed in order to reach the agreement between the author and publisher. As the journal is fully open access, the authors will sign an exclusive license agreement.
The authors have the right to:
- Share their article in the same ways permitted to third parties under the relevant user license.
- Retain copyright, patent, trademark and other intellectual property rights including research data.
- Proper attribution and credit for the published work.
For the open access article, the publisher is granted to the following right.
- The non-exclusive right to publish the article and grant right to others.
- For the published article, the publisher applied for the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
